Daily BriefsIndonesia

Daily Brief Indonesia: Prodia, Bank Mandiri Persero and more

In today’s briefing:

  • Prodia (PRDA IJ) – Diagnosing a Return to Healthy Profits
  • Bank Mandiri (BMRI IJ) – Dancing to a Digital Tune


Prodia (PRDA IJ) – Diagnosing a Return to Healthy Profits

By Angus Mackintosh

  • Prodia (PRDA IJ) remains Indonesia’s relatively undiscovered diagnostics leader, with a strong market position, long-term relationships with the medical community, and an increasingly digital edge through its MyProdia app. 
  • The compamy continues to experience a high-base effect from COVID but has seen a dramatic increase in tests per visit as patients become increasingly helath conscious. 
  • Prodia (PRDA IJ) is significantly cheaper than its Indian comparables, trading on half the valuation, despite being a high-quality player tapping into a large increasingly health-conscious population.

Bank Mandiri (BMRI IJ) – Dancing to a Digital Tune

By Angus Mackintosh

  • Bank Mandiri (BMRI IJ) stands out from its SOE peers in the progress it has made in digitising its business through the Livin’ mobile app and KOPRA for corporate customers.
  • The bank continues to outperform in terms of loan growth and risk management, which is reflected in a higher ROE and lower credit costs as LAR continue to decline.  
  • Bank Mandiri should see a strong finish to the year well within guidance, with a healthy outlook for 2024 given its healthy capital position and competitive cost base. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars